Shares of Nikola and GM surged Tuesday after announcing that GM would invest $2B in Nikola, holding a 11% stake in the electric vehicle company. GM will engineer and produce Nikola’s ‘Badger’ pickup. The Final Round panel breaks down the details …read more […]
We’re entering my favorite time of year.
It’s not my favorite because I love fall or the cornucopia of pumpkin-spice-flavored goodies. Or because I’m a fan of winter. (In fact, I hate all those things.)
I love this time of year because it’s the busiest season for trend traders like me.
And despite the pandemic’s best efforts, the world hasn’t ground to a halt. Life adapts and pushes forward. We’ve witnessed this time and time again this year.
That’s why I believe that as we dive headlong into the final two quarters of 2020 (thankfully!), we’re going to experience record spending poised to reward …read more […]
(Bloomberg) — Elon Musk’s net worth plunged $16.3 billion Tuesday, the largest single-day wipeout in the history of the Bloomberg Billionaires Index, as the Tesla Inc. rout continued.The electric-carmaker fell 21% in New York trading — the most ever — on news of a partnership between competitors Nikola Corp. and General Motors Co., deepening a sell-off that began last week after it was snubbed for inclusion in the S&P 500 index.The world’s wealthiest people have lately seen wild swings in their net worth as retail traders accelerate buying and selling in stocks. Amazon.com Inc’s Jeff Bezos lost $7.9 billion Tuesday, …read more […]
No, we’re not hitting the end of a second dot-com bubble. …read more […]
On Tuesday, nine top drugmaker companies – such as Merck, Pfizer, and Johnson and Johnson – announced that they all pledge to uphold ‘safety’ and ‘integrity’ as the rush for a coronavirus vaccine is worrying health officials about the potential consequences of their studies. Yahoo Finance’s Anjalee Khemlani breaks down the latest news about the coronavirus on The Final Round. …read more […]
Investors are signalling that maybe the old warrior has some fight left. …read more […]
Explosive seems like the only word that adequately describes Trillium Therapeutics’ (TRIL) gains in 2020. The immuno-oncology company has taken off on an upward trajectory, and is up by a whopping 833% year-to-date. However, over the last few days, shares have experienced a pullback. Does the sell-off indicate the tides are turning?No, says JonesTrading’s Soumit Roy. In fact, the five-star analyst argues any weakness presents investors with a chance to get in on the action.What exactly is behind his bullish thesis? Part of Roy’s excitement is related to I-Mab’s recently announced partnership with AbbVie. The agreement, which will see AbbVie …read more […]
Lululemon released its second quarter earnings report after hours on Tuesday, beating investors’ estimates on both revenue and earnings per share. The company announced that it would not be providing any detailed guidance for its 2020 fiscal year, with the CEO telling investors he was ‘cautiously optimistic’ for the second half the year. Yahoo Finance’s Myles Udland breaks down the fitness brand’s earnings report on The Final Round. …read more […]
Workplace collaboration app Slack posted fiscal second-quarter earnings after the bell today. The company has been seen as a winner during the coronavirus pandemic, as entire workforces have had to mobilize online. …read more […]
Berkshire is expected to purchase another 4 million shares from a stockholder in a secondary transaction. …read more […]
Warren Buffett turned 90 on August 30.
But it was investors who got a surprise.
On the same day, the Oracle of Omaha revealed that a Berkshire subsidiary had taken a 5% stake in five major Japanese trading houses.
With $146.6 billion in cash to spend, Berkshire’s cash kitty barely saw a dent from the $6 billion investment.
Still, Berkshire’s foray into the Japanese stocks marked a sea change in Buffett’s thinking.
Click here to watch Nicholas’ latest video update.
Buffett has often said he has trouble finding good deals in the U.S. After all, trendy tech stocks have driven U.S. indexes to all-time highs.
So you …read more […]
The Proposition 22 ballot campaign by Uber and Lyft just became the most expensive such campaign ever. …read more […]
A month is a long time on Wall Street. For one of 2020’s star performers, it has been a stark reminder how quickly sentiment can turn.Over the past month, shares of Inovio Pharmaceuticals (INO) have plummeted by 50% as the tides have turned against this high-flying coronavirus stock. Faced with stiff competition in the race to be first to market with a COVID-19 vaccine, investors have seemingly lost confidence in the small biotech’s ability to beat its bigger rivals.But not all on the Street have lowered expectations. Benchmark analyst Aydin Huseynov reiterated a Buy on INO shares alongside a $36 …read more […]
(Bloomberg) — Moderna Inc. fell as much as 13% on Tuesday after regulators and top drugmakers promised the Covid-19 vaccine approval process would be immune from political pressure and the biotech company drew its first sell rating since going public in 2018.Moderna’s vaccine is one of three leading candidates Wall Street expects may win an emergency use authorization near-term.. But pledges from the Food and Drug Administration and industry leaders have cast a pall over the prospects of a vaccine being approved before the U.S. election.The public letter signed by nine chief executive officers may not shift study schedules “all …read more […]
With some of the most powerful nations in the world sinking into recession due to the coronavirus pandemic, there are questions around investing during a recession and how you can manage your wealth right now.
The situation is changing by the day, with uncertainty around the stability of the US dollar and a weakened global economy. With so many unknowns, it can be difficult to know what to do next. Do you invest now, before the situation changes? Or sit tight and wait to see what unfolds towards the end of the year?
Although there are those who believe that now is …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
